Canada’s PharmaDrug signs agreement to acquire Securedose Synthetics
The deal will be effected by way of a three-cornered amalgamation between SecureDose, Pharmadrug and its wholly owned subsidiary. As per the terms of this transaction, all the
Under the deal, Moderna will utilise Caris’ library of de-identified, multi-modal data solutions generated from whole exome sequencing, whole transcriptome sequencing, and protein analyses, in addition to claims
PCI will be responsible for the formulation, packaging, and distribution of a siRNA-based investigational injectable treatment for inflammatory dermatological conditions. The organisation will carry out all these activities